Details for: SVIL
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 53.44rCSI 76.69%PRS 40.98
-
CSI 31.29rCSI 47.79%PRS 51.06
-
CSI 28.24rCSI 90.91%PRS 49.22
-
CSI 26.44rCSI 37.73%PRS 52.89
-
CSI 24.19rCSI 19.55%PRS 60.39
-
CSI 23.07rCSI 55.47%PRS 59.75
-
CSI 21.2rCSI 27.22%PRS 44.85
-
CSI 20.53rCSI 35.99%PRS 42.5
-
CSI 19.12rCSI 52.52%PRS 65.49
-
CSI 17.97rCSI 56.2%PRS 37.45
-
CSI 17.68rCSI 31.77%PRS 43.69
-
CSI 17.44rCSI 25.52%PRS 53.81
-
CSI 17.28rCSI 56.24%PRS 51.78
-
CSI 14.28rCSI 36.13%PRS 58.7
-
CSI 13.61rCSI 53.19%PRS 58.05
-
CSI 13.17rCSI 29.1%PRS 37.89
-
CSI 13.16rCSI 82.2%PRS 42.57
-
CSI 12.98rCSI 32.12%PRS 48.28
-
CSI 12.33rCSI 19.69%PRS 54.39
-
CSI 12.05rCSI 8.46%PRS 70.85
-
CSI 11.67rCSI 33.8%PRS 52.55
-
CSI 11.35rCSI 30.32%PRS 42.44
-
CSI 11.3rCSI 16.57%PRS 61.87
-
CSI 11rCSI 17.55%PRS 43.94
-
CSI 10.89rCSI 26.6%PRS 45.3
-
CSI 10.68rCSI 17.18%PRS 35.82
-
CSI 10.51rCSI 35.21%PRS 37.39
-
CSI 9.73rCSI 20.18%PRS 47.94
-
CSI 9.7rCSI 19.92%PRS 71.25
-
CSI 9.65rCSI 14.27%PRS 55.77
-
CSI 9.56rCSI 11.83%PRS 46.21
-
CSI 9.52rCSI 18.15%PRS 67.07
-
CSI 9.51rCSI 28.23%PRS 60.96
-
CSI 9.38rCSI 7.05%PRS 54.62
-
CSI 9.06rCSI 16.97%PRS 39.57
-
CSI 9.05rCSI 25.9%PRS 66.11
-
CSI 8.85rCSI 35.72%PRS 48.75
-
CSI 8.38rCSI 6.34%PRS 63.79
-
CSI 8rCSI 12.3%PRS 50.25
-
CSI 7.94rCSI 9.89%PRS 61.61
-
CSI 7.67rCSI 37.8%PRS 62.07
-
CSI 7.35rCSI 12.71%PRS 40.82
-
CSI 6.9rCSI 22.38%PRS 52.61
-
CSI 6.85rCSI 8.34%PRS 58.27
-
CSI 6.75rCSI 16.09%PRS 61.4
-
CSI 6.67rCSI 11.19%PRS 33.71
-
CSI 6.54rCSI 10.59%PRS 48.3
-
CSI 6.5rCSI 15%PRS 40.99
-
CSI 6.5rCSI 11.63%PRS 48.94
-
CSI 6.41rCSI 5.38%PRS 55.39
-
CSI 6.27rCSI 9.98%PRS 43.03
-
CSI 6.21rCSI 12.07%PRS 52.64
-
CSI 6.02rCSI 35.52%PRS 46.65
-
CSI 6.01rCSI 32.34%PRS 65.09
-
CSI 5.95rCSI 13.58%PRS 43.24
-
CSI 5.91rCSI 5.09%PRS 57.79
-
CSI 5.89rCSI 8.06%PRS 55.68
-
CSI 5.85rCSI 6.76%PRS 44.47
-
CSI 5.83rCSI 22.04%PRS 34.57
-
CSI 5.73rCSI 8.85%PRS 48.22
-
CSI 5.64rCSI 6.81%PRS 58.54
-
CSI 5.56rCSI 5.8%PRS 50.92
-
CSI 5.43rCSI 12.12%PRS 57.4
-
CSI 5.42rCSI 4.69%PRS 54.74
-
CSI 5.41rCSI 10.98%PRS 31.85
-
CSI 5.36rCSI 19.3%PRS 32.48
-
CSI 5.36rCSI 6.29%PRS 53.57
-
CSI 5.35rCSI 25.63%PRS 49.28
-
CSI 5.15rCSI 3.81%PRS 43.43
-
CSI 5.11rCSI 22.46%PRS 47.54
-
CSI 5.06rCSI 4.45%PRS 39.14
-
CSI 4.99rCSI 11.86%PRS 61.55
-
CSI 4.98rCSI 5.07%PRS 64.05
-
CSI 4.96rCSI 6.37%PRS 48.29
-
CSI 4.95rCSI 6.86%PRS 54.05
-
CSI 4.78rCSI 13.18%PRS 46.51
-
CSI 4.72rCSI 5.66%PRS 48.32
-
CSI 4.69rCSI 25.63%PRS 51.33
-
CSI 4.65rCSI 8.21%PRS 32.79
-
CSI 4.64rCSI 6.45%PRS 49.79
-
CSI 4.63rCSI 4.46%PRS 40.99
-
CSI 4.51rCSI 3.66%PRS 50.92
-
CSI 4.34rCSI 10.56%PRS 32.62
-
CSI 4.32rCSI 5.66%PRS 64.07
-
CSI 4.29rCSI 4.59%PRS 48.68
-
CSI 4.28rCSI 2.97%PRS 60.24
-
CSI 4.25rCSI 2.96%PRS 64.26
-
CSI 4.24rCSI 8.71%PRS 43.12
-
CSI 4.23rCSI 5.77%PRS 43.23
-
CSI 4.19rCSI 10.62%PRS 40.34
-
CSI 4.18rCSI 3.86%PRS 51.37
-
CSI 4.14rCSI 22.02%PRS 44.44
-
CSI 4.12rCSI 8.27%PRS 39.93
-
CSI 4.08rCSI 3.62%PRS 48.94
-
CSI 4.08rCSI 11.8%PRS 66.63
-
CSI 4.07rCSI 4.07%PRS 44.34
-
CSI 4.05rCSI 12.94%PRS 47.06
-
CSI 4.03rCSI 6.15%PRS 59.83
-
CSI 4.02rCSI 3.18%PRS 37.74
-
CSI 3.96rCSI 5.61%PRS 46.95
-
CSI 0.2rCSI 5.9%PRS 34.1%
-
CSI 0.3rCSI 6.4%PRS 73.7%
-
CSI 0.3rCSI 2.9%PRS 65.7%
-
CSI 0.3rCSI 1.9%PRS 67.1%
-
CSI 0.4rCSI 4.4%PRS 77.4%
-
CSI 0.5rCSI 3.4%PRS 69.3%
-
CSI 0.5rCSI 11.6%PRS 73.9%
-
CSI 0.6rCSI 4.7%PRS 37.6%
-
CSI 0.7rCSI 2.9%PRS 66.0%
-
CSI 0.7rCSI 1.2%PRS 66.7%
-
CSI 0.7rCSI 12.2%PRS 80.8%
-
CSI 0.7rCSI 3.0%PRS 61.5%
-
CSI 0.8rCSI 1.9%PRS 55.7%
-
CSI 0.8rCSI 1.7%PRS 70.3%
-
CSI 0.8rCSI 3.3%PRS 70.3%
-
CSI 0.9rCSI 6.1%PRS 42.3%
-
CSI 0.9rCSI 2.7%PRS 35.1%
-
CSI 0.9rCSI 5.1%PRS 72.6%
-
CSI 0.9rCSI 7.8%PRS 74.2%
-
CSI 0.9rCSI 5.7%PRS 54.7%
-
CSI 0.9rCSI 1.2%PRS 55.7%
-
CSI 0.9rCSI 6.8%PRS 37.8%
-
CSI 1.0rCSI 11.0%PRS 80.2%
-
CSI 1.0rCSI 8.8%PRS 49.8%
-
CSI 1.0rCSI 1.4%PRS 77.5%
-
CSI 1.1rCSI 2.5%PRS 66.5%
-
CSI 1.1rCSI 4.0%PRS 42.6%
-
CSI 1.1rCSI 7.2%PRS 48.3%
-
CSI 1.2rCSI 7.5%PRS 81.1%
-
CSI 1.2rCSI 3.3%PRS 48.9%
-
CSI 1.2rCSI 9.6%PRS 44.2%
-
CSI 1.2rCSI 2.0%PRS 61.3%
-
CSI 1.3rCSI 3.2%PRS 45.7%
-
CSI 1.3rCSI 11.6%PRS 65.1%
-
CSI 1.3rCSI 1.7%PRS 55.2%
-
CSI 1.3rCSI 9.3%PRS 44.9%
-
CSI 1.3rCSI 2.1%PRS 51.6%
-
CSI 1.3rCSI 3.8%PRS 41.1%
-
CSI 1.3rCSI 3.4%PRS 54.9%
-
CSI 1.3rCSI 7.4%PRS 65.1%
-
CSI 1.3rCSI 7.9%PRS 35.1%
-
CSI 1.4rCSI 4.8%PRS 65.1%
-
CSI 1.4rCSI 2.1%PRS 55.1%
-
CSI 1.4rCSI 3.6%PRS 57.3%
-
CSI 1.4rCSI 2.0%PRS 60.3%
-
CSI 1.4rCSI 7.2%PRS 63.3%
-
CSI 1.4rCSI 3.6%PRS 46.1%
-
CSI 1.4rCSI 7.0%PRS 81.8%
-
CSI 1.4rCSI 1.1%PRS 51.3%
-
CSI 1.4rCSI 22.1%PRS 54.9%
-
CSI 1.5rCSI 2.5%PRS 59.9%
-
CSI 1.5rCSI 2.9%PRS 72.9%
-
CSI 1.5rCSI 5.0%PRS 79.4%
-
CSI 1.5rCSI 2.2%PRS 67.8%
-
CSI 1.5rCSI 6.9%PRS 82.9%
-
CSI 1.6rCSI 9.4%PRS 60.9%
-
CSI 1.6rCSI 7.5%PRS 67.8%
-
CSI 1.6rCSI 9.4%PRS 51.1%
-
CSI 1.6rCSI 11.7%PRS 52.4%
-
CSI 1.6rCSI 2.1%PRS 56.2%
-
CSI 1.7rCSI 7.3%PRS 42.9%
-
CSI 1.7rCSI 3.0%PRS 65.6%
-
CSI 1.7rCSI 7.1%PRS 68.9%
-
CSI 1.8rCSI 18.7%PRS 50.2%
-
CSI 1.8rCSI 2.6%PRS 66.9%
-
CSI 1.8rCSI 11.5%PRS 64.4%
-
CSI 1.8rCSI 8.2%PRS 71.1%
-
CSI 1.9rCSI 2.5%PRS 45.6%
-
CSI 1.9rCSI 14.3%PRS 64.5%
-
CSI 1.9rCSI 2.0%PRS 56.3%
-
CSI 1.9rCSI 13.1%PRS 47.2%
-
CSI 2.0rCSI 5.8%PRS 48.6%
-
CSI 2.0rCSI 2.6%PRS 34.8%
-
CSI 2.0rCSI 4.8%PRS 51.9%
-
CSI 2.0rCSI 3.4%PRS 55.9%
-
CSI 2.0rCSI 4.0%PRS 70.2%
-
CSI 2.1rCSI 2.6%PRS 52.8%
-
CSI 2.1rCSI 1.6%PRS 49.7%
-
CSI 2.2rCSI 5.7%PRS 58.6%
-
CSI 2.2rCSI 4.7%PRS 54.5%
-
CSI 2.2rCSI 4.9%PRS 48.2%
-
CSI 2.2rCSI 5.9%PRS 58.8%
-
CSI 2.2rCSI 5.2%PRS 60.1%
-
CSI 2.3rCSI 6.6%PRS 77.0%
-
CSI 2.3rCSI 3.1%PRS 63.0%
-
CSI 2.4rCSI 11.4%PRS 50.4%
-
CSI 2.5rCSI 4.4%PRS 58.7%
-
CSI 2.6rCSI 2.8%PRS 54.1%
-
CSI 2.6rCSI 6.7%PRS 49.5%
-
CSI 2.6rCSI 3.0%PRS 40.4%
-
CSI 2.7rCSI 2.8%PRS 47.3%
-
CSI 2.7rCSI 15.3%PRS 60.7%
-
CSI 2.7rCSI 6.0%PRS 59.8%
-
CSI 2.8rCSI 4.2%PRS 53.1%
-
CSI 2.8rCSI 6.4%PRS 73.3%
-
CSI 2.8rCSI 3.7%PRS 51.6%
-
CSI 2.9rCSI 7.5%PRS 70.8%
-
CSI 2.9rCSI 6.6%PRS 49.8%
-
CSI 2.9rCSI 5.5%PRS 72.0%
-
CSI 3.0rCSI 4.5%PRS 66.2%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 866758052
Symbol: SVIL_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9867483
Title: Cloning, characterization, and chromosomal localization of human supervillin (SVIL).
PubMed ID: 9867483
PubMed ID: 12711699
Title: Archvillin, a muscle-specific isoform of supervillin, is an early expressed component of the costameric membrane skeleton.
PubMed ID: 12711699
DOI: 10.1242/jcs.00422
PubMed ID: 23382381
Title: Supervillin-mediated suppression of p53 protein enhances cell survival.
PubMed ID: 23382381
PubMed ID: 15164054
Title: The DNA sequence and comparative analysis of human chromosome 10.
PubMed ID: 15164054
DOI: 10.1038/nature02462
PubMed ID: 17081983
Title: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
PubMed ID: 17081983
PubMed ID: 17525332
Title: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.
PubMed ID: 17525332
PubMed ID: 18639526
Title: Archvillin anchors in the Z-line of skeletal muscle via the nebulin C-terminus.
PubMed ID: 18639526
PubMed ID: 18220336
Title: Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.
PubMed ID: 18220336
DOI: 10.1021/pr0705441
PubMed ID: 18088087
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19109420
Title: Supervillin reorganizes the actin cytoskeleton and increases invadopodial efficiency.
PubMed ID: 19109420
PubMed ID: 19690332
Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
PubMed ID: 19690332
PubMed ID: 20068231
Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
PubMed ID: 20068231
PubMed ID: 21406692
Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
PubMed ID: 21406692
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 24275569
Title: An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
PubMed ID: 24275569
PubMed ID: 24129315
Title: Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.
PubMed ID: 24129315
PubMed ID: 32779703
Title: Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles.
PubMed ID: 32779703
PubMed ID: 19683541
Title: How to arm a supervillin: designing F-actin binding activity into supervillin headpiece.
PubMed ID: 19683541
Sequence Information:
- Length: 2214
- Mass: 247746
- Checksum: 6C4793D31FCBDF7C
- Sequence:
MKRKERIARR LEGIENDTQP ILLQSCTGLV THRLLEEDTP RYMRASDPAS PHIGRSNEEE ETSDSSLEKQ TRSKYCTETS GVHGDSPYGS GTMDTHSLES KAERIARYKA ERRRQLAEKY GLTLDPEADS EYLSRYTKSR KEPDAVEKRG GKSDKQEESS RDASSLYPGT ETMGLRTCAG ESKDYALHVG DGSSDPEVLL NIENQRRGQE LSATRQAHDL SPAAESSSTF SFSGRDSSFT EVPRSPKHAH SSSLQQAASR SPSFGDPQLS PEARPSTGKP KHEWFLQKDS EGDTPSLINW PSRVKVREKL VKEESARNSP ELASESVTQR RHQPAPVHYV SFQSEHSAFD RVPSKAAGST RQPIRGYVQP ADTGHTAKLV TPETPENASE CSWVASATQN VPKPPSLTVL EGDGRDSPVL HVCESKAEEE EGEGEGEEKE EDVCFTEALE QSKKTLLALE GDGLVRSPED PSRNEDFGKP AVSTVTLEHQ KELENVAQPP QAPHQPTERT GRSEMVLYIQ SEPVSQDAKP TGHNREASKK RKVRTRSLSD FTGPPQLQAL KYKDPASRRE LELPSSKTEG PYGEISMLDT KVSVAQLRSA FLASANACRR PELKSRVERS AEGPGLPTGV ERERGSRKPR RYFSPGESRK TSERFRTQPI TSAERKESDR CTSHSETPTV DDEEKVDERA KLSVAAKRLL FREMEKSFDE QNVPKRRSRN TAVEQRLRRL QDRSLTQPIT TEEVVIAATE PIPASCSGGT HPVMARLPSP TVARSAVQPA RLQASAHQKA LAKDQTNEGK ELAEQGEPDS STLSLAEKLA LFNKLSQPVS KAISTRNRID TRQRRMNARY QTQPVTLGEV EQVQSGKLIP FSPAVNTSVS TVASTVAPMY AGDLRTKPPL DHNASATDYK FSSSIENSDS PVRSILKSQA WQPLVEGSEN KGMLREYGET ESKRALTGRD SGMEKYGSFE EAEASYPILN RAREGDSHKE SKYAVPRRGS LERANPPITH LGDEPKEFSM AKMNAQGNLD LRDRLPFEEK VEVENVMKRK FSLRAAEFGE PTSEQTGTAA GKTIAQTTAP VSWKPQDSSE QPQEKLCKNP CAMFAAGEIK TPTGEGLLDS PSKTMSIKER LALLKKSGEE DWRNRLSRRQ EGGKAPASSL HTQEAGRSLI KKRVTESRES QMTIEERKQL ITVREEAWKT RGRGAANDST QFTVAGRMVK KGLASPTAIT PVASPICGKT RGTTPVSKPL EDIEARPDMQ LESDLKLDRL ETFLRRLNNK VGGMHETVLT VTGKSVKEVM KPDDDETFAK FYRSVDYNMP RSPVEMDEDF DVIFDPYAPK LTSSVAEHKR AVRPKRRVQA SKNPLKMLAA REDLLQEYTE QRLNVAFMES KRMKVEKMSS NSNFSEVTLA GLASKENFSN VSLRSVNLTE QNSNNSAVPY KRLMLLQIKG RRHVQTRLVE PRASALNSGD CFLLLSPHCC FLWVGEFANV IEKAKASELA TLIQTKRELG CRATYIQTIE EGINTHTHAA KDFWKLLGGQ TSYQSAGDPK EDELYEAAII ETNCIYRLMD DKLVPDDDYW GKIPKCSLLQ PKEVLVFDFG SEVYVWHGKE VTLAQRKIAF QLAKHLWNGT FDYENCDINP LDPGECNPLI PRKGQGRPDW AIFGRLTEHN ETILFKEKFL DWTELKRSNE KNPGELAQHK EDPRTDVKAY DVTRMVSMPQ TTAGTILDGV NVGRGYGLVE GHDRRQFEIT SVSVDVWHIL EFDYSRLPKQ SIGQFHEGDA YVVKWKFMVS TAVGSRQKGE HSVRAAGKEK CVYFFWQGRH STVSEKGTSA LMTVELDEER GAQVQVLQGK EPPCFLQCFQ GGMVVHSGRR EEEEENVQSE WRLYCVRGEV PVEGNLLEVA CHCSSLRSRT SMVVLNVNKA LIYLWHGCKA QAHTKEVGRT AANKIKEQCP LEAGLHSSSK VTIHECDEGS EPLGFWDALG RRDRKAYDCM LQDPGSFNFA PRLFILSSSS GDFAATEFVY PARAPSVVSS MPFLQEDLYS APQPALFLVD NHHEVYLWQG WWPIENKITG SARIRWASDR KSAMETVLQY CKGKNLKKPA PKSYLIHAGL EPLTFTNMFP SWEHREDIAE ITEMDTEVSN QITLVEDVLA KLCKTIYPLA DLLARPLPEG VDPLKLEIYL TDEDFEFALD MTRDEYNALP AWKQVNLKKA KGLF
Genular Protein ID: 3161805019
Symbol: A0A6I8PIX7_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15164054
Title: The DNA sequence and comparative analysis of human chromosome 10.
PubMed ID: 15164054
DOI: 10.1038/nature02462
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
Sequence Information:
- Length: 1904
- Mass: 213628
- Checksum: FDF44527E80206F6
- Sequence:
MKRKERIARR LEGIENDTQP ILLQSCTGLV THRLLEEDTP RYMRASDPAS PHIGRSNEEE ETSDSSLEKQ TRSKYCTETS GVHGDSPYGS GTMDTHSLES KAERIARYKA ERRRQLAEKY GLTLDPEADS EYLSRYTKSR KEPDAVEKRG GKSDKQEESS RDASSLYPGT ETMGLRTCAG ESKDYALHVG DGSSDPEVLL NIENQRRGQE LSATRQAHDL SPAAESSSTF SFSGRDSSFT EVPRSPKHAH SSSLQQAASR SPSFGDPQLS PEARPSTGKP KHEWFLQKDS EGDTPSLINW PSSKSRVERS AEGPGLPTGV ERERGSRKPR RYFSPGESRK TSERFRTQPI TSAERKESDR CTSHSETPTV DDEEKVDERA KLSVAAKRLL FREMEKSFDE QNVPKRRSRN TAVEQRLRRL QDRSLTQPIT TEEVVIAATE PIPASCSGGT HPVMARLPSP TVARSAVQPA RLQASAHQKA LAKDQTNEGK ELAEQGEPDS STLSLAEKLA LFNKLSQPVS KAISTRNRID TRQRRMNARY QTQPVTLGEV EQVQSGKLIP FSPAVNTSVS TVASTVAPMY AGDLRTKPPL DHNASATDYK FSSSIENSDS PVRSILKSQA WQPLVEGSEN KGMLREYGET ESKRALTGRD SGMEKYGSFE EAEASYPILN RAREGDSHKE SKYAVPRRGS LERANPPITH LGDEPKEFSM AKMNAQGNLD LRDRLPFEEK VEVENVMKRK FSLRAAEFGE PTSEQTGTAA GKTIAQTTAP VSWKPQDSSE QPQEKLCKNP CAMFAAGEIK TPTGEGLLDS PSKTMSIKER LALLKKSGEE DWRNRLSRRQ EGGKAPASSL HTQEAGRSLI KKRVTESRES QMTIEERKQL ITVREEAWKT RGRGAANDST QFTVAGRMVK KGLASPTAIT PVASPICGKT RGTTPVSKPL EDIEARPDMQ LESDLKLDRL ETFLRRLNNK VGGMHETVLT VTGKSVKEVM KPDDDETFAK FYRSVDYNMP RSPVEMDEDF DVIFDPYAPK LTSSVAEHKR AVRPKRRVQA SKNPLKMLAA REDLLQEYTE QRLNVAFMES KRMKVEKMSS NSNFSEVTLA GLASKENFSN VSLRSVNLTE QNSNNSAVPY KRLMLLQIKG RRHVQTRLVE PRASALNSGD CFLLLSPHCC FLWVGEFANV IEKAKASELA TLIQTKRELG CRATYIQTIE EGINTHTHAA KDFWKLLGGQ TSYQSAGDPK EDELYEAAII ETNCIYRLMD DKLVPDDDYW GKIPKCSLLQ PKEVLVFDFG SEVYVWHGKE VTLAQRKIAF QLAKHLWNGT FDYENCDINP LDPGECNPLI PRKGQGRPDW AIFGRLTEHN ETILFKEKFL DWTELKRSNE KNPGELAQHK EDPRTDVKAY DVTRMVSMPQ TTAGTILDGV NVGRGYGLVE GHDRRQFEIT SVSVDVWHIL EFDYSRLPKQ SIGQFHEGDA YVVKWKFMVS TAVGSRQKGE HSVRAAGKEK CVYFFWQGRH STVSEKGTSA LMTVELDEER GAQVQVLQGK EPPCFLQCFQ GGMVVHSGRR EEEEENVQSE WRLYCVRGEV PVEGNLLEVA CHCSSLRSRT SMVVLNVNKA LIYLWHGCKA QAHTKEVGRT AANKIKEQCP LEAGLHSSSK VTIHECDEGS EPLGFWDALG RRDRKAYDCM LQDPGSFNFA PRLFILSSSS GDFAATEFVY PARAPSVVSS MPFLQEDLYS APQPALFLVD NHHEVYLWQG WWPIENKITG SARIRWASDR KSAMETVLQY CKGKNLKKPA PKSYLIHAGL EPLTFTNMFP SWEHREDIAE ITEMDTEVSN QITLVEDVLA KLCKTIYPLA DLLARPLPEG VDPLKLEIYL TDEDFEFALD MTRDEYNALP AWKQVNLKKA KGLF
Genular Protein ID: 4027591256
Symbol: Q569J5_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
Sequence Information:
- Length: 81
- Mass: 9243
- Checksum: B878DC8ADFCB16CB
- Sequence:
MDTEVSNQIT LVEDVLAKLC KTIYPLADLL ARPLPEGVDP LKLEIYLTDE DFEFALDMTR DEYNALPAWK QVNLKKAKGL F